Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria

In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applyin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurovirology 2012-06, Vol.18 (3), p.191-199
Hauptverfasser: Royal, Walter, Cherner, Mariana, Carr, Jean, Habib, Abdulrazaq G., Akomolafe, Abimbola, Abimiku, Alashl’e., Charurat, Manhattan, Farley, John, Oluyemisi, Akinwande, Mamadu, Ibrahim, Johnson, Joyce, Ellis, Ronald, McCutchen, J. Allen, Grant, Igor, Blattner, William A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 199
container_issue 3
container_start_page 191
container_title Journal of neurovirology
container_volume 18
creator Royal, Walter
Cherner, Mariana
Carr, Jean
Habib, Abdulrazaq G.
Akomolafe, Abimbola
Abimiku, Alashl’e.
Charurat, Manhattan
Farley, John
Oluyemisi, Akinwande
Mamadu, Ibrahim
Johnson, Joyce
Ellis, Ronald
McCutchen, J. Allen
Grant, Igor
Blattner, William A.
description In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.
doi_str_mv 10.1007/s13365-012-0097-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1069202709</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1017617743</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxiMEoqXwAFyQL0hcAv4Tx84RrQqtVMEFuFqOM1lNldiLnay0r8BTMyUL3BDywaNvfjMjfV9VvRT8reDcvCtCqVbXXMia887Up0fVpdDK1rJp1GOqlaautM1F9ayUe86FaqV9Wl1IqUm1_LL6sZswYvATG8Eva4bCfBzYIcOEM0afT6ws64Ckp5EdMacp7X_xIWWC_LJ1Iqw5hbSPuOARGM4Hj3mGuDA_p7hnN7ffaowjhAUGhnHAIw6rnwrV7BPuIaN_Xj0ZSYEX5_-q-vrh-svupr77_PF29_6uDo3mS910FrrBGt_2gg9BwNj3QC9IckOTOnA79uC7XlnZK6m8boXtgBttjTJSXVVvtr2HnL6vUBY3YwkwTT5CWosTvO0kl4Z3_4EK0wpjGkWo2NCQUykZRnfIOJN_BLmHtNyWlqO03ENa7kQzr87r136G4c_E73gIeH0GfCHPx-xjwPKX050VndLEyY0r1IrkprtPa47k4j-u_wRFobAk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1017617743</pqid></control><display><type>article</type><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</creator><creatorcontrib>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</creatorcontrib><description>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</description><identifier>ISSN: 1355-0284</identifier><identifier>EISSN: 1538-2443</identifier><identifier>DOI: 10.1007/s13365-012-0097-y</identifier><identifier>PMID: 22528480</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Adult ; Batteries ; Biological and medical sciences ; Biomedical and Life Sciences ; Biomedicine ; Cognition ; Cognition Disorders - epidemiology ; Cognition Disorders - etiology ; Cognition Disorders - virology ; Cognitive ability ; Corticotropin-releasing hormone ; Dementia disorders ; DNA Fingerprinting ; Female ; HIV Infections - complications ; HIV Infections - psychology ; HIV Seronegativity ; HIV Seropositivity ; HIV-1 - genetics ; HIV-1 - isolation &amp; purification ; Human immunodeficiency virus 1 ; Human viral diseases ; Humans ; Immunology ; Infection ; Infectious Diseases ; Male ; Medical sciences ; Neurology ; Neuropsychological Tests ; Neurosciences ; Nigeria - epidemiology ; Research Design ; Risk Factors ; Task Performance and Analysis ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Viral diseases of the nervous system ; Viral Load ; Virology</subject><ispartof>Journal of neurovirology, 2012-06, Vol.18 (3), p.191-199</ispartof><rights>Journal of NeuroVirology, Inc. 2012</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</citedby><cites>FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s13365-012-0097-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s13365-012-0097-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25981935$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22528480$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Royal, Walter</creatorcontrib><creatorcontrib>Cherner, Mariana</creatorcontrib><creatorcontrib>Carr, Jean</creatorcontrib><creatorcontrib>Habib, Abdulrazaq G.</creatorcontrib><creatorcontrib>Akomolafe, Abimbola</creatorcontrib><creatorcontrib>Abimiku, Alashl’e.</creatorcontrib><creatorcontrib>Charurat, Manhattan</creatorcontrib><creatorcontrib>Farley, John</creatorcontrib><creatorcontrib>Oluyemisi, Akinwande</creatorcontrib><creatorcontrib>Mamadu, Ibrahim</creatorcontrib><creatorcontrib>Johnson, Joyce</creatorcontrib><creatorcontrib>Ellis, Ronald</creatorcontrib><creatorcontrib>McCutchen, J. Allen</creatorcontrib><creatorcontrib>Grant, Igor</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><title>Journal of neurovirology</title><addtitle>J. Neurovirol</addtitle><addtitle>J Neurovirol</addtitle><description>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</description><subject>Adult</subject><subject>Batteries</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cognition</subject><subject>Cognition Disorders - epidemiology</subject><subject>Cognition Disorders - etiology</subject><subject>Cognition Disorders - virology</subject><subject>Cognitive ability</subject><subject>Corticotropin-releasing hormone</subject><subject>Dementia disorders</subject><subject>DNA Fingerprinting</subject><subject>Female</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - psychology</subject><subject>HIV Seronegativity</subject><subject>HIV Seropositivity</subject><subject>HIV-1 - genetics</subject><subject>HIV-1 - isolation &amp; purification</subject><subject>Human immunodeficiency virus 1</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunology</subject><subject>Infection</subject><subject>Infectious Diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Neuropsychological Tests</subject><subject>Neurosciences</subject><subject>Nigeria - epidemiology</subject><subject>Research Design</subject><subject>Risk Factors</subject><subject>Task Performance and Analysis</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Viral diseases of the nervous system</subject><subject>Viral Load</subject><subject>Virology</subject><issn>1355-0284</issn><issn>1538-2443</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc9u1DAQxiMEoqXwAFyQL0hcAv4Tx84RrQqtVMEFuFqOM1lNldiLnay0r8BTMyUL3BDywaNvfjMjfV9VvRT8reDcvCtCqVbXXMia887Up0fVpdDK1rJp1GOqlaautM1F9ayUe86FaqV9Wl1IqUm1_LL6sZswYvATG8Eva4bCfBzYIcOEM0afT6ws64Ckp5EdMacp7X_xIWWC_LJ1Iqw5hbSPuOARGM4Hj3mGuDA_p7hnN7ffaowjhAUGhnHAIw6rnwrV7BPuIaN_Xj0ZSYEX5_-q-vrh-svupr77_PF29_6uDo3mS910FrrBGt_2gg9BwNj3QC9IckOTOnA79uC7XlnZK6m8boXtgBttjTJSXVVvtr2HnL6vUBY3YwkwTT5CWosTvO0kl4Z3_4EK0wpjGkWo2NCQUykZRnfIOJN_BLmHtNyWlqO03ENa7kQzr87r136G4c_E73gIeH0GfCHPx-xjwPKX050VndLEyY0r1IrkprtPa47k4j-u_wRFobAk</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Royal, Walter</creator><creator>Cherner, Mariana</creator><creator>Carr, Jean</creator><creator>Habib, Abdulrazaq G.</creator><creator>Akomolafe, Abimbola</creator><creator>Abimiku, Alashl’e.</creator><creator>Charurat, Manhattan</creator><creator>Farley, John</creator><creator>Oluyemisi, Akinwande</creator><creator>Mamadu, Ibrahim</creator><creator>Johnson, Joyce</creator><creator>Ellis, Ronald</creator><creator>McCutchen, J. Allen</creator><creator>Grant, Igor</creator><creator>Blattner, William A.</creator><general>Springer US</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20120601</creationdate><title>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</title><author>Royal, Walter ; Cherner, Mariana ; Carr, Jean ; Habib, Abdulrazaq G. ; Akomolafe, Abimbola ; Abimiku, Alashl’e. ; Charurat, Manhattan ; Farley, John ; Oluyemisi, Akinwande ; Mamadu, Ibrahim ; Johnson, Joyce ; Ellis, Ronald ; McCutchen, J. Allen ; Grant, Igor ; Blattner, William A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-498e9d87a6b10dc1efbbebebc21335a6bd08fbea9b382b323a56189e075873723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Batteries</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cognition</topic><topic>Cognition Disorders - epidemiology</topic><topic>Cognition Disorders - etiology</topic><topic>Cognition Disorders - virology</topic><topic>Cognitive ability</topic><topic>Corticotropin-releasing hormone</topic><topic>Dementia disorders</topic><topic>DNA Fingerprinting</topic><topic>Female</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - psychology</topic><topic>HIV Seronegativity</topic><topic>HIV Seropositivity</topic><topic>HIV-1 - genetics</topic><topic>HIV-1 - isolation &amp; purification</topic><topic>Human immunodeficiency virus 1</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunology</topic><topic>Infection</topic><topic>Infectious Diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Neuropsychological Tests</topic><topic>Neurosciences</topic><topic>Nigeria - epidemiology</topic><topic>Research Design</topic><topic>Risk Factors</topic><topic>Task Performance and Analysis</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Viral diseases of the nervous system</topic><topic>Viral Load</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Royal, Walter</creatorcontrib><creatorcontrib>Cherner, Mariana</creatorcontrib><creatorcontrib>Carr, Jean</creatorcontrib><creatorcontrib>Habib, Abdulrazaq G.</creatorcontrib><creatorcontrib>Akomolafe, Abimbola</creatorcontrib><creatorcontrib>Abimiku, Alashl’e.</creatorcontrib><creatorcontrib>Charurat, Manhattan</creatorcontrib><creatorcontrib>Farley, John</creatorcontrib><creatorcontrib>Oluyemisi, Akinwande</creatorcontrib><creatorcontrib>Mamadu, Ibrahim</creatorcontrib><creatorcontrib>Johnson, Joyce</creatorcontrib><creatorcontrib>Ellis, Ronald</creatorcontrib><creatorcontrib>McCutchen, J. Allen</creatorcontrib><creatorcontrib>Grant, Igor</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of neurovirology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Royal, Walter</au><au>Cherner, Mariana</au><au>Carr, Jean</au><au>Habib, Abdulrazaq G.</au><au>Akomolafe, Abimbola</au><au>Abimiku, Alashl’e.</au><au>Charurat, Manhattan</au><au>Farley, John</au><au>Oluyemisi, Akinwande</au><au>Mamadu, Ibrahim</au><au>Johnson, Joyce</au><au>Ellis, Ronald</au><au>McCutchen, J. Allen</au><au>Grant, Igor</au><au>Blattner, William A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria</atitle><jtitle>Journal of neurovirology</jtitle><stitle>J. Neurovirol</stitle><addtitle>J Neurovirol</addtitle><date>2012-06-01</date><risdate>2012</risdate><volume>18</volume><issue>3</issue><spage>191</spage><epage>199</epage><pages>191-199</pages><issn>1355-0284</issn><eissn>1538-2443</eissn><abstract>In Nigeria, the incidence and prevalence of human immunodeficiency virus (HIV)-related neurocognitive impairment (NCI) are unknown and there currently exists little information related to the viral correlates rates of NCI. Therefore, studies were performed to examine the potential utility of applying an established neuropsychological (NP) screening battery and detailed NP testing to detect NCI and correlations with functional impairment and the presence of specific viral signatures among infected subjects. A total of 60 HIV-1 seropositive antiretroviral-naive individuals and 56 seronegative control subjects were administered the International HIV Dementia Scale (IHDS) and assessed for functional impairment using the Karnofsky performance status scale. Fifteen HIV-infected patients and 11 controls were also administered a detailed NP battery. Blood samples from eight infected subjects, three with evidence of NCI, were obtained for molecular analysis of HIV-1 strain. Unadjusted scores on the IHDS showed that, using a recommended total score cutoff of 10, 28.8 % of the HIV-1 seropositive and 16.0 % of seropositive individuals scored abnormally. Results from testing using the full NP battery showed that, overall, the HIV seropositive group performed worse than the seronegative group, with effect sizes spanning from small (0.25 on the trail making test A) to large (0.82 on action fluency), and an average effect size across the battery of 0.45, which approaches that which has been recorded in other international settings. Sequencing of partial pol amplicons from viral isolates revealed that two of three patients with NCI were infected with subtype G virus and 1 with the circulating recombinant form (CRF)02_AG; all four individuals without NCI were infected with CRF_02AG. These studies demonstrate the utility of the IHDS in identifying cognitive impairment among HIV infected individuals in Nigeria. Future studies aimed at examining the burden of NCI among the population of individuals with HIV-1 infection in Nigeria and which assess the virologic correlates will contribute to the evolving understanding of the pathogenetic factors that underlie this disorder.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>22528480</pmid><doi>10.1007/s13365-012-0097-y</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-0284
ispartof Journal of neurovirology, 2012-06, Vol.18 (3), p.191-199
issn 1355-0284
1538-2443
language eng
recordid cdi_proquest_miscellaneous_1069202709
source MEDLINE; Springer Nature - Complete Springer Journals
subjects Adult
Batteries
Biological and medical sciences
Biomedical and Life Sciences
Biomedicine
Cognition
Cognition Disorders - epidemiology
Cognition Disorders - etiology
Cognition Disorders - virology
Cognitive ability
Corticotropin-releasing hormone
Dementia disorders
DNA Fingerprinting
Female
HIV Infections - complications
HIV Infections - psychology
HIV Seronegativity
HIV Seropositivity
HIV-1 - genetics
HIV-1 - isolation & purification
Human immunodeficiency virus 1
Human viral diseases
Humans
Immunology
Infection
Infectious Diseases
Male
Medical sciences
Neurology
Neuropsychological Tests
Neurosciences
Nigeria - epidemiology
Research Design
Risk Factors
Task Performance and Analysis
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Viral diseases of the nervous system
Viral Load
Virology
title Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T04%3A34%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20features%20and%20preliminary%20studies%20of%20virological%20correlates%20of%20neurocognitive%20impairment%20among%20HIV-infected%20individuals%20in%20Nigeria&rft.jtitle=Journal%20of%20neurovirology&rft.au=Royal,%20Walter&rft.date=2012-06-01&rft.volume=18&rft.issue=3&rft.spage=191&rft.epage=199&rft.pages=191-199&rft.issn=1355-0284&rft.eissn=1538-2443&rft_id=info:doi/10.1007/s13365-012-0097-y&rft_dat=%3Cproquest_cross%3E1017617743%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1017617743&rft_id=info:pmid/22528480&rfr_iscdi=true